| RYCCX | RYNVX | RYCCX / RYNVX | |
| Total Expense Ratio | 2.50 | 1.32 | 189% |
| Annual Report Gross Expense Ratio | 2.62 | 1.37 | 191% |
| Fund Existence | 26 years | 33 years | - |
| Gain YTD | 17.910 | 12.534 | 143% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.59B | 249M | 639% |
| Annual Yield % from dividends | 0.00 | 0.67 | - |
| Returns for 1 year | 21.42 | 24.91 | 86% |
| Returns for 3 years | 97.39 | 91.63 | 106% |
| Returns for 5 years | 62.38 | 45.44 | 137% |
| Returns for 10 years | 686.82 | 288.18 | 238% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GFFDX | 86.21 | 1.51 | +1.78% |
| Invesco Global Focus R5 | |||
| FREIX | 37.40 | 0.23 | +0.62% |
| Franklin Equity Income R | |||
| VIVIX | 85.78 | -0.24 | -0.28% |
| Vanguard Morn Value Index Institutional | |||
| VSFCX | 25.95 | -0.09 | -0.35% |
| Federated Hermes MDT Small Cap Value C | |||
| PHSZX | 50.32 | -0.58 | -1.14% |
| PGIM Jennison Health Sciences Z | |||